Ma-Weaver Jacob 4
4 · ARCA biopharma, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Ma-Weaver Jacob
Other
Transactions
- Award
Stock option (right to buy)
2024-01-30+6,000→ 6,000 totalExercise: $1.64Exp: 2034-01-30→ Common stock (6,000 underlying)
Footnotes (2)
- [F1]This Form 4 is filed by Jacob Ma-Weaver. Mr. Ma-Weaver, Funicular Funds, LP, and Cable Car Capital LLC may be deemed to be members of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- [F2]Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 30, 2024, subject to the Reporting Person continuing to provide Continuous Service (as defined in the 2020 Equity Incentive Plan) through such date. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.